Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
384,509,293
-
Total 13F shares
-
190,036,694
-
Share change
-
+15,973,275
-
Total reported value
-
$5,692,045,262
-
Put/Call ratio
-
58%
-
Price per share
-
$29.95
-
Number of holders
-
274
-
Value change
-
+$497,302,583
-
Number of buys
-
212
-
Number of sells
-
69
Institutional Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q1 2020
As of 31 Mar 2020,
Moderna, Inc. - COMMON STOCK (MRNA) was held by
274 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
190,036,694 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Theleme Partners LLP, STATE STREET CORP, MORGAN STANLEY, Invesco Ltd., Bellevue Group AG, and BAILLIE GIFFORD & CO.
This page lists
276
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.